case series:anlotinib and etoposide
Sponsors
Liaoning Cancer Hospital & Institute, Beijing Hospital
Conditions
Ovarian cancersmall cell lung cancer
Phase 4
The efficacy and safety of enlotinib combined with etoposide in the treatment of small cell lung cancer after failure of second-line chemotherapy
RecruitingChiCTR2000030474
Start: 2020-03-10Updated: 2020-03-09
The efficacy and safety of arotinib combined with etoposide in the treatment of platinum resistant recurrent ovarian cancer
Active, not recruitingChiCTR2000031558
Start: 2020-06-01Updated: 2020-04-06